The pathophysiology of autism spectrum disorder (ASD) is not yet known; however, studies suggest that dysfunction of the immune system affects many children with ASD. Increasing evidence points to dysfunction of the innate immune system including activation of microglia and perivascular macrophages, increases in inflammatory cytokines/chemokines in brain tissue and CSF, and abnormal peripheral monocyte cell function. Dendritic cells are major players in innate immunity and have important functions in the phagocytosis of pathogens or debris, antigen presentation, activation of naïve T cells, induction of tolerance and cytokine/chemokine production. In this study, we assessed circulating frequencies of myeloid dendritic cells (defined as Lin-1 ) in 57 children with ASD, and 29 typically developing controls of the same age, all of who were enrolled as part of the Autism Phenome Project (APP). The frequencies of dendritic cells and associations with behavioral assessment and MRI measurements of amygdala volume were compared in the same participants. The frequencies of myeloid dendritic cells were significantly increased in children with ASD compared to typically developing controls (p < 0.03). Elevated frequencies of myeloid dendritic cells were positively associated with abnormal right and left amygdala enlargement, severity of gastrointestinal symptoms and increased repetitive behaviors. The frequencies of plasmacytoid dendritic cells were also associated with amygdala volumes as well as developmental regression in children with ASD. Dendritic cells play key roles in modulating immune responses and differences in frequencies or functions of these cells may result in immune dysfunction in children with ASD. These data further implicate innate immune cells in the complex pathophysiology of ASD.
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Introduction
Autism spectrum disorder (ASD) appears early in childhood and is characterized by core features of impaired social interaction, deficits in communication and restricted repetitive behaviors and interests (APA, 2000) . Once thought of as a rare disorder the prevalence rates for ASD are now considered to be approximately 1% of all children (MMWR, 2009) . The etiology and pathophysiology of ASD largely remain a mystery but are likely to involve complex interactions between genetic, epigenetic and environmental factors. Rapidly accumulating evidence highlights a role for dysfunctional immune responses in many children with ASD (Onore et al., 2012) . Many candidate genes linked with ASD have influence over immune responses while immune dysfunction in the brain and periphery have been reported (Abrahams and Geschwind, 2008; Ashwood et al., 2011a; Vargas et al., 2005) . Furthermore, models of maternal immune activation cast light on how aberrant immune responses during critical periods of development can cause changes in neurodevelopment that lead to altered behaviors resembling those of core autistic features (Patterson, 2009) .
Several lines of evidence point to ongoing and prominent activation of innate immune cells within the brain, such as microglia and perivascular macrophages (Vargas et al., 2005; Morgan et al., 2010; Voineagu et al., 2011) . Further studies have shown increased activation of monocytes in the periphery following stimulation with Toll-like receptor ligands, including changes in gene expression, increased HLA-DR cell surface expression and the release of pro-inflammatory cytokines interleukin (IL)-1b and IL-6 (Enstrom et al., 2010; Jyonouchi et al., 2001) . Moreover, circulating levels of cytokines exhibit a profile reminiscent of innate immune cell
